{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:48:17Z","timestamp":1770835697557,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Temple University School of Pharmacy"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bmcl.2018.05.040","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T22:19:05Z","timestamp":1526941145000},"page":"2270-2274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17\u03b1-hydroxylase-C17,20-lyase (Cyp17)"],"prefix":"10.1016","volume":"28","author":[{"given":"Benjamin E.","family":"Blass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magid","family":"Abou-Gharbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne E.","family":"Childers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercy","family":"Ramanjulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Premkumar","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshodeep","family":"Boruwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Ellingboe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayan","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajashekar","family":"Reddy Nimmareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalini","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamallamudi","family":"Rajasekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savithiri","family":"Shivakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratima","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghuram S.","family":"Tangirala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konda","family":"Venkataramanaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramreddy","family":"Bobbala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Yanamandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Krishnakanth Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2018.05.040_b0005","unstructured":"Berg JM, Tymoczko JL, Gatto Jr GJ, Stryer L, Freeman WH. Biochemistry. 8th ed. New York; 2015."},{"key":"10.1016\/j.bmcl.2018.05.040_b0010","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ddr.20124","article-title":"Glucocorticoids in type 2 diabetes mellitus and the metabolic syndrome","volume":"67","author":"Welles","year":"2006","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmcl.2018.05.040_h0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1758834016642370","article-title":"CYP17 inhibitors in prostate cancer: latest evidence and clinical potential","volume":"8","author":"Alex","year":"2016","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.bmcl.2018.05.040_h0020","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrc1211","volume":"3","author":"Johnston","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmcl.2018.05.040_h0025","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1021\/jm00013a022","article-title":"Novel steroidal inhibitors of human cytochrome P45017\u03b1-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer","volume":"38","author":"Potter","year":"1995","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.bmcl.2018.05.040_h0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrd3516","article-title":"Abiraterone acetate","volume":"10","author":"Logothetis","year":"2011","journal-title":"Nat Rev Drug Disc"},{"key":"10.1016\/j.bmcl.2018.05.040_h0035","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.bmcl.2014.04.024","article-title":"Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors","volume":"24","author":"Rafferty","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.05.040_h0040","unstructured":"Clinical trials: Phase 2: NCT02445976, NCT02130700."},{"key":"10.1016\/j.bmcl.2018.05.040_h0045","unstructured":"Bock MG, Gaul C, Gummadi V Rao, Sengupta S. Preparation of disubstituted imidazolidinone derivatives as cytochrome P450, 17\u03b1-hydroxylase, c17\u201320 lyase inhibitors WO2010149755; 2010."},{"key":"10.1016\/j.bmcl.2018.05.040_h0050","unstructured":"Clinical trials: Phase 2 NCT01647789."},{"key":"10.1016\/j.bmcl.2018.05.040_h0055","unstructured":"Koziol TR. Methods and compositions for the treatment of Cushing\u2019s Syndrome using 2S,4R-ketoconazole, WO2016048984A1; 2016."},{"key":"10.1016\/j.bmcl.2018.05.040_h0060","unstructured":"Clinical trial for Endogenous Cushing\u2019s Syndrome, NCT01838551, Phase 3."},{"key":"10.1016\/j.bmcl.2018.05.040_b0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pharmthera.2005.07.006","article-title":"CYP17- and CYP11B-dependent steroid hydroxylases as drug development targets","volume":"111","author":"Hakki","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmcl.2018.05.040_b0045","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1016\/j.bmcl.2016.10.016","article-title":"Synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for metabolic syndrome","volume":"26","author":"Blass","year":"2016","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18304414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18304414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:24:03Z","timestamp":1760772243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X18304414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":14,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0960894X18304414"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.05.040","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17\u03b1-hydroxylase-C17,20-lyase (Cyp17)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}